NFKB1 and breast carcinoma: Consistently, we have demonstrated the effect of osteolytic breast cancer bone metastases on muscle weakness and muscle fiber atrophy via bone-matrix–derived TGF-ß and activated p38/NF-κB signaling cascade [27••].